Evidence map›Paper›PMID 41870960›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Predicting and Rationalizing Piezoelectricity in Racemic Bioorganic Molecular Crystals.

Shubham Vishnoi, Sarah Guerin

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shubham VishnoiDepartment of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland.ORCID https://orcid.org/0000-0002-8213-5931
Sarah GuerinDepartment of Chemical Sciences, Bernal Institute, University of Limerick, Limerick, Ireland.ORCID https://orcid.org/0000-0002-2442-4022

Funding

European Union 101039636Research Ireland 12/RC/2275_P2Research Ireland 21/PATH-S/9737
6 · The paper itself

Abstract

Racemic crystals, often presumed to favour centrosymmetric packing and lack polar functionality, conceal an unlikely and underexplored capacity for longitudinal piezoelectricity. Here, we report a broad computational exploration demonstrating that certain bioorganic racemic systems exhibit pronounced piezoelectric responses, comparable to leading single-crystal materials. Despite their inherent mirror symmetry at the molecular level, the modelled crystal structures lack inversion symmetry, giving rise to significant electrical polarisation under mechanical stress, as predicted by our density functional theory (DFT) calculations. Our top-performing stable racemic crystals exhibit effective longitudinal piezoelectric strain response of up to 28 pC/N, more than twice that of benchmark DL-alanine (12.5 pC/N), combined with low dielectric constants (<5) and high mechanical flexibility. These results position our modelled racemic molecular systems as a promising, bio-friendly platform for soft, sustainable and lead-free piezoelectric devices. Our findings overturn conventional assumptions about the structural and functional limitations of racemic crystals as a material class, revealing their suitability for next-generation piezoelectric applications. Six of the racemic organic systems studied exhibit piezoelectric strain coefficients exceeding 10 pC/N, highlighting their viability as efficient and environmentally friendly alternatives to conventional inorganic materials.

Indexed as

bioorganic materialsdensity functional theory (DFT)lead‐free electromechanical materialsracemic crystalssustainable piezoelectrics

Identifiers

PMID41870960
PMCPMC13285477

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.